SmartCells

Insulin and polymer-based products for the treatment of diabetes, fertility, thyroid, and growth hormone deficiencies.

Launch date

Aug 2003

Employees

Market cap

Enterprise valuation

$500m (Public information from Dec 2010)

Beverly Massachusetts (HQ)

http://smartinsulin.com

https://www.linkedin.com/company/149278/

Date	Investors	Amount	Round
Aug 2003	N/A	N/A	Grant
Dec 2003	Boston Harbor Angels	N/A	Angel
Sep 2004	Boston Harbor Angels	$500k	Series A
Apr 2005	Angel Healthcare Investors Boston Harbor Angels	$1.0m	Series A
Aug 2005	National Institute of Diabetes and Digestive and Kidney Diseases	N/A	Grant
May 2006	Cherrystone Angels	N/A	Series B
Apr 2007	National Institute of Diabetes and Digestive and Kidney Diseases	$390k	Grant
Aug 2007	National Institute of Diabetes and Digestive and Kidney Diseases	$280k	Grant
May 2008	Cherrystone Angels	N/A	Series C
Sep 2008	National Institute of Diabetes and Digestive and Kidney Diseases	$1.5m	Grant
May 2009	Cherrystone Angels Converge Venture Partners Angel Healthcare Investors Boston Harbor Angels	$4.1m	Series D
Jul 2009	N/A	$1.1m	Debt
Jun 2010	Beacon Angels Cherrystone Angels Angel Healthcare Investors Boston Harbor Angels	$4.1m	Series D
Dec 2010	Merck	$500m Valuation: $500m	Acquisition
Total Funding		$11.9m